Literature DB >> 3348001

Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene.

K Koike1, T Akatsuka, T Miyamura.   

Abstract

To elucidate the biological role of the X region of HBV DNA, we constructed an expression plasmid pSV2HBx by inserting the StuI/BglII fragment of HBV DNA into the pSV2 vector. Although X region products were not identified in vivo in transfected COS-1 cells, transcripts were translated in vitro and a 17-k Da protein was immunoprecipitated with an antibody raised against a synthetic peptide corresponding to the carboxy terminus of the X region open reading frame. Among 68 HBV carrier sera tested, two were found to contain antibodies reactive to the in vitro translation product. These results suggest that the X region is a gene which can be actually expressed at some stage of HBV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348001     DOI: 10.1016/0042-6822(88)90256-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic active hepatitis.

Authors:  R Abraham; H W Doerr; W Braun; M Stemler; H Will; G Hess; C H Schröder
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

2.  Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors:  T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Mapping of B-cell epitopes of the human hepatitis B virus X protein.

Authors:  M Stemler; T Weimer; Z X Tu; D F Wan; M Levrero; C Jung; G R Pape; H Will
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.

Authors:  K Koike; K Moriya; H Yotsuyanagi; S Iino; K Kurokawa
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.